(Yicai Global) May 14 -- Morgan Stanley Capital International will add 26 more so-called A-shares to its MSCI China Index including 18 from the ChiNext Price Index, which tracks growth enterprises listed in Shenzhen.
The New York-based index compiler will also boost the inclusion factor of all Chinese large-cap shares in MSCI indexes to 10 percent from 5 percent following its semi-annual review. The results of the review will take effect after May 28.
The newly added ChiNext stocks include Lepu Medical Technology [SHE:300003], Aier Eye Hospital Group [SHE:300015], Wangsu Science & Technology [SHE:300017] and Zhejiang Nuclear New Flush Network Information [SHE:300033] among others.
Some 29 stocks will be added to the MSCI China A Mid Cap Index along with five removals bringing the total to 173, while adjustments will also be made to the MSCI China A Onshore Indexes.
A-shares, or stocks traded on Chinese mainland exchanges, will have an aggregate weight of 5.25 percent and 1.76 percent in the MSCI China and MSCI Emerging Markets Indexes, respectively, after the completion.
The company said that external uncertainties and market volatility would not affect its decision to increase the index inclusion factor of A-shares.
Editor: William Clegg